Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Horwitz, Ariel Halper-Stromberg, H. Mouquet, Alexander Gitlin, A. Tretiakova, Thomas Eisenreich, M. Malbec, S. Gravemann, E. Billerbeck, M. Dorner, H. Büning, O. Schwartz, E. Knops, R. Kaiser, M. Seaman, James Wilson, C. Rice, A. Ploss, P. Bjorkman, F. Klein, M. Nussenzweig (2013)
HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized miceProceedings of the National Academy of Sciences, 110
B. Descours, V. Avettand-Fenoel, C. Blanc, A. Samri, A. Mélard, V. Supervie, I. Theodorou, G. Carcelain, C. Rouzioux, B. Autran (2012)
Immune responses driven by protective human leukocyte antigen alleles from long-term nonprogressors are associated with low HIV reservoir in central memory CD4 T cells.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 54 10
Ariel Halper-Stromberg, Ching-Lan Lu, F. Klein, J. Horwitz, S. Bournazos, Lilian Nogueira, Thomas Eisenreich, Cassie Liu, A. Gazumyan, Uwe Schaefer, Rebecca Furze, M. Seaman, R. Prinjha, A. Tarakhovsky, J. Ravetch, M. Nussenzweig (2014)
Broadly Neutralizing Antibodies and Viral Inducers Decrease Rebound from HIV-1 Latent Reservoirs in Humanized MiceCell, 158
A. Okoye, L. Picker (2013)
CD4+ T‐cell depletion in HIV infection: mechanisms of immunological failureImmunological Reviews, 254
T. Le, J. Farrar, C. Shikuma (2011)
Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication.AIDS, 25 6
N. Archin, N. Vaidya, J. Kuruc, A. Liberty, A. Wiegand, Mary Kearney, M. Cohen, J. Coffin, R. Bosch, C. Gay, J. Eron, D. Margolis, A. Perelson (2012)
Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infectionProceedings of the National Academy of Sciences, 109
D. Barouch, S. Deeks (2014)
Immunologic strategies for HIV-1 remission and eradicationScience, 345
M. Buzón, E. Martín-Gayo, F. Pereyra, Zhengyu Ouyang, Hong Sun, Jonathan Li, M. Piovoso, A. Shaw, J. Dalmau, Nadine Zangger, J. Martinez-Picado, R. Zurakowski, Xu Yu, A. Telenti, B. Walker, E. Rosenberg, M. Lichterfeld (2014)
Long-Term Antiretroviral Treatment Initiated at Primary HIV-1 Infection Affects the Size, Composition, and Decay Kinetics of the Reservoir of HIV-1-Infected CD4 T CellsJournal of Virology, 88
Y. Ho, L. Shan, Nina Hosmane, Jeffrey Wang, S. Laskey, Daniel Rosenbloom, J. Lai, J. Blankson, J. Siliciano, R. Siliciano (2013)
Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 CureCell, 155
T. Chun, D. Engel, M. Berrey, T. Shea, L. Corey, A. Fauci (1998)
Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection.Proceedings of the National Academy of Sciences of the United States of America, 95 15
(2014)
Early treatment in acute SIV infection limits the size and distribution of the viral reservoir. In: Conference on Retroviruses and Opportunistic Infections (internet)
G. Doitsh, N. Galloway, X. Geng, Zhiyuan Yang, K. Monroe, O. Zepeda, P. Hunt, H. Hatano, S. Sowinski, Isa Muñoz-Arias, W. Greene (2013)
Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infectionNature, 505
N. Soriano-Sarabia, Rosalie Bateson, Noelle Dahl, A. Crooks, J. Kuruc, D. Margolis, N. Archin (2014)
Quantitation of Replication-Competent HIV-1 in Populations of Resting CD4+ T CellsJournal of Virology, 88
G. Hütter, D. Nowak, M. Mossner, S. Ganepola, A. Müssig, Kristina Allers, T. Schneider, J. Hofmann, C. Kücherer, O. Blau, I. Blau, W. Hofmann, E. Thiel (2009)
Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation.The New England journal of medicine, 360 7
(2013)
Early ART intervention restricts the seeding of the HIV reservoir in long-lived central memory CD4 T cells
A. Hill, Daniel Rosenbloom, Feng Fu, M. Nowak, R. Siliciano (2014)
Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1Proceedings of the National Academy of Sciences, 111
D. Persaud, H. Gay, C. Ziemniak, Y. Chen, M. Piatak, T. Chun, M. Strain, D. Richman, K. Luzuriaga (2013)
Absence of detectable HIV-1 viremia after treatment cessation in an infant.The New England journal of medicine, 369 19
(2015)
Wolters Kluwer Health, Inc. All rights reserved
T. Benen, P. Tonks, A. Kliche, Ruth Kapzan, J. Heeney, R. Wagner (2014)
Development and immunological assessment of VLP-based immunogens exposing the membrane-proximal region of the HIV-1 gp41 proteinJournal of Biomedical Science, 21
(2000)
dose-escalation study of the safety, pharmacokinetics and antiretroviral activity of 3BNC117 monoclonal antibody in HIV-infected and HIV-uninfected volunteers
T. Chun, D. Murray, J. Justement, J. Blazkova, C. Hallahan, Olivia Fankuchen, Kathleen Gittens, E. Benko, C. Kovacs, S. Moir, A. Fauci (2014)
Broadly neutralizing antibodies suppress HIV in the persistent viral reservoirProceedings of the National Academy of Sciences, 111
S. Lam, C. Bollard (2013)
T-cell therapies for HIV.Immunotherapy, 5 4
T. Chun, J. Justement, S. Moir, C. Hallahan, J. Maenza, James Mullins, Ann Collier, L. Corey, A. Fauci (2007)
Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus.The Journal of infectious diseases, 195 12
T. Henrich, Emily Hanhauser, F. Marty, M. Sirignano, S. Keating, Tzong-Hae Lee, Yvonne Robles, B. Davis, Jonathan Li, Andrea Heisey, A. Hill, M. Busch, P. Armand, R. Soiffer, M. Altfeld, D. Kuritzkes (2014)
Antiretroviral-Free HIV-1 Remission and Viral Rebound After Allogeneic Stem Cell TransplantationAnnals of Internal Medicine, 161
A. West, L. Scharf, J. Scheid, F. Klein, P. Bjorkman, M. Nussenzweig (2014)
Structural Insights on the Role of Antibodies in HIV-1 Vaccine and TherapyCell, 156
M. Shingai, Y. Nishimura, F. Klein, H. Mouquet, Olivia Donau, R. Plishka, A. Buckler-White, M. Seaman, M. Piatak, J. Lifson, D. Dimitrov, M. Nussenzweig, Malcolma Martin (2013)
Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemiaNature, 503
A. Balazs, Y. Ouyang, C. Hong, Joyce Chen, Steven Nguyen, D. Rao, Dong An, David Baltimore (2012)
Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmissionRetrovirology, 9
Michelle D’Souza, A. Fontenot, D. Mack, C. Lozupone, S. Dillon, Amie Meditz, Cara Wilson, E. Connick, B. Palmer (2007)
Programmed Death 1 Expression on HIV-Specific CD4+ T Cells Is Driven by Viral Replication and Associated with T Cell Dysfunction1The Journal of Immunology, 179
James Williams, J. Hurst, W. Stöhr, N. Robinson, Helen Brown, M. Fisher, S. Kinloch, D. Cooper, M. Schechter, G. Tambussi, S. Fidler, M. Carrington, A. Babiker, J. Weber, K. Koelsch, A. Kelleher, R. Phillips, J. Frater (2014)
HIV-1 DNA predicts disease progression and post-treatment virological controleLife, 3
M. Markowitz, Teresa Evering, D. Garmon, M. Caskey, M. Mar, K. Rodriguez, V. Sahi, S. Palmer, N. Prada, H. Mohri (2014)
A Randomized Open-Label Study of 3- Versus 5-Drug Combination Antiretroviral Therapy in Newly HIV-1–Infected IndividualsJAIDS Journal of Acquired Immune Deficiency Syndromes, 66
N. Chomont, M. El-Far, P. Ancuța, L. Trautmann, F. Procopio, B. Yassine-Diab, G. Boucher, M. Boulassel, G. Ghattas, J. Brenchley, T. Schacker, Brenna Hill, D. Douek, J. Routy, E. Haddad, R. Sékaly (2009)
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferationNature Medicine, 15
Study of the safety and pharmacokinetics of a human monoclonal antibody , VRC - HIVMAB 060 - 00 - AB ( VRC 01 ) administered intravenously or subcutaneously to healthy adults
Mengfei Liu, Guang Yang, K. Wiehe, N. Nicely, N. Vandergrift, W. Rountree, M. Bonsignori, S. Alam, Jingyun Gao, B. Haynes, G. Kelsoe (2014)
Polyreactivity and Autoreactivity among HIV-1 AntibodiesJournal of Virology, 89
J. Whitney, A. Hill, Srisowmya Sanisetty, P. Penaloza-MacMaster, Jinyan Liu, Mayuri Shetty, Lily Parenteau, Crystal Cabral, Jennifer Shields, S. Blackmore, Jeffrey Smith, Amanda Brinkman, L. Peter, Sheeba Mathew, Kaitlin Smith, E. Borducchi, Daniel Rosenbloom, M. Lewis, J. Hattersley, Bei Li, J. Hesselgesser, R. Geleziunas, M. Robb, Jerome Kim, N. Michael, D. Barouch (2014)
Rapid Seeding of the Viral Reservoir Prior to SIV Viremia in Rhesus MonkeysNature, 512
D. Barouch, J. Whitney, B. Moldt, F. Klein, Thiago Oliveira, Jinyan Liu, K. Stephenson, Hui-Wen Chang, K. Shekhar, Sanjana Gupta, Joseph Nkolola, M. Seaman, Kaitlin Smith, E. Borducchi, Crystal Cabral, Jeffrey Smith, S. Blackmore, Srisowmya Sanisetty, J. Perry, M. Beck, M. Lewis, William Rinaldi, A. Chakraborty, P. Poignard, M. Nussenzweig, D. Burton (2013)
Therapeutic Efficacy of Potent Neutralizing HIV-1-Specific Monoclonal Antibodies in SHIV-Infected Rhesus MonkeysNature, 503
J. Ananworanich, J. Fletcher, S. Pinyakorn, F. Griensven, C. Vandergeeten, A. Schuetz, T. Pankam, R. Trichavaroj, S. Akapirat, N. Chomchey, P. Phanuphak, N. Chomont, N. Michael, Jerome Kim, M. Souza (2013)
A novel acute HIV infection staging system based on 4th generation immunoassayRetrovirology, 10
J. Ananworanich, A. Schuetz, C. Vandergeeten, I. Sereti, M. Souza, R. Rerknimitr, R. Dewar, M. Marovich, F. Griensven, R. Sékaly, S. Pinyakorn, N. Phanuphak, R. Trichavaroj, Wiriya Rutvisuttinunt, N. Chomchey, R. Paris, S. Peel, V. Valcour, F. Maldarelli, N. Chomont, N. Michael, P. Phanuphak, Jerome Kim (2012)
Impact of Multi-Targeted Antiretroviral Treatment on Gut T Cell Depletion and HIV Reservoir Seeding during Acute HIV InfectionPLoS ONE, 7
A. Sáez-Cirión, C. Bacchus, L. Hocqueloux, V. Avettand-Fenoel, I. Girault, C. Lécuroux, V. Potard, P. Versmisse, A. Mélard, T. Prazuck, B. Descours, J. Guergnon, J. Viard, F. Boufassa, O. Lambotte, C. Goujard, L. Meyer, D. Costagliola, A. Venet, G. Pancino, B. Autran, C. Rouzioux (2013)
Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI StudyPLoS Pathogens, 9
F. Klein, Ariel Halper-Stromberg, J. Horwitz, H. Gruell, J. Scheid, S. Bournazos, H. Mouquet, L. Spatz, R. Diskin, A. Abadir, Trinity Zang, M. Dorner, E. Billerbeck, Rachael Labitt, C. Gaebler, P. Marcovecchio, R. Incesu, Thomas Eisenreich, P. Bieniasz, M. Seaman, P. Bjorkman, J. Ravetch, A. Ploss, M. Nussenzweig (2012)
HIV therapy by a combination of broadly neutralizing antibodies in humanized miceNature, 492
S. Hansen, Julia Ford, Matthew Lewis, A. Ventura, Colette Hughes, Lia Coyne-Johnson, Nathan Whizin, K. Oswald, R. Shoemaker, Tonya Swanson, Alfred Legasse, M. Chiuchiolo, C. Parks, M. Axthelm, J. Nelson, M. Jarvis, M. Piatak, J. Lifson, L. Picker (2011)
Profound early control of highly pathogenic SIV by an effector-memory T cell vaccineNature, 473
REVIEW URRENT Broadly neutralizing antibody and the HIV reservoir PINION in acute HIV infection: a strategy toward HIV remission? a,b a,b a,b Jintanat Ananworanich , Brian McSteen , and Merlin L. Robb Purpose of review Infection of long-lived CD4 T cells is a major obstacle to HIV remission, and antiretroviral therapy (ART) instituted during acute HIV infection restricts HIV reservoir establishment. Broadly neutralizing antibodies (bNAbs) may be employed in conjunction with early ART as strategies toward HIV remission. Recent findings Proof-of-concept studies in vitro and in animal models demonstrated bNAbs’ ability to block viral entry into cells, suppress viremia and reduce cell-associated viral DNA. Combination bNAbs were more effective than single bNAb in suppressing viremia. When bNAb was used with ART with or without combination latency reversing agents, it prevented viral rebound after ART interruption in at least half of the animals. In one study, macaques with low baseline viral load achieved viral remission even after the blood bNAb titer was no longer detected. Summary The acute HIV infection period represents a unique opportunity to explore the use of bNAbs with ART to limit the reservoir seeding that may enhance the chance of HIV remission. This article discusses the
Current Opinion in HIV and Aids – Wolters Kluwer Health
Published: May 1, 2015
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.